Published in Oncogene on May 22, 1997
Induction and utilization of an ATM signaling pathway by polyomavirus. J Virol (2005) 1.53
Simian virus 40 large T antigen targets the spindle assembly checkpoint protein Bub1. Proc Natl Acad Sci U S A (2004) 1.42
Partial MCM4 deficiency in patients with growth retardation, adrenal insufficiency, and natural killer cell deficiency. J Clin Invest (2012) 1.35
Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J Virol (2008) 1.35
Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J Virol (2010) 1.23
Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ Health Perspect (1999) 1.22
Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer. Annu Rev Pathol (2009) 1.20
Simian virus 40 activates ATR-Delta p53 signaling to override cell cycle and DNA replication control. J Virol (2010) 1.03
Strategies for immortalization of primary hepatocytes. J Hepatol (2014) 0.93
Overexpression of simian virus 40 small-T antigen blocks centrosome function and mitotic progression in human fibroblasts. J Virol (2001) 0.88
Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection. J Virol (2003) 0.87
Induction and bypass of p53 during productive infection by polyomavirus. J Virol (2002) 0.85
Replication stress and mitotic dysfunction in cells expressing simian virus 40 large T antigen. J Virol (2013) 0.81
Comparative transcriptome profiling of an SV40-transformed human fibroblast (MRC5CVI) and its untransformed counterpart (MRC-5) in response to UVB irradiation. PLoS One (2013) 0.78
The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene. J Bone Marrow Res (2013) 0.75
Occurrence of TRGV-BJ hybrid gene in SV40-transformed fibroblast cell lines. Genetica (2009) 0.75
The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol (1989) 8.68
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
Chemokines and the arrest of lymphocytes rolling under flow conditions. Science (1998) 5.34
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15
Mutations in RPE65 cause autosomal recessive childhood-onset severe retinal dystrophy. Nat Genet (1997) 4.87
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A (1995) 4.15
Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet (2000) 3.72
TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell (1990) 3.55
The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science (1986) 3.37
The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity. EMBO J (1988) 3.20
Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature (1987) 3.12
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5. Proc Natl Acad Sci U S A (2000) 3.10
Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med (1997) 2.99
An evaluation of the mini-Wright peak flow meter. Thorax (1979) 2.91
Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem (1999) 2.89
Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science (1986) 2.89
GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer (1999) 2.77
6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. J Cell Biol (1998) 2.62
44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids. Mol Cell Biol (1988) 2.50
Activation of cyclin A-dependent protein kinases during apoptosis. Proc Natl Acad Sci U S A (1994) 2.29
Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology (1997) 2.29
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics (1997) 2.28
Immunohistochemical localization of keratin in normal human tissues. Lab Invest (1980) 2.28
Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein. EMBO J (1987) 2.23
Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J Virol (1999) 2.23
Effect of streptolysin O on erythrocyte membranes, liposomes, and lipid dispersions. A protein-cholesterol interaction. J Cell Biol (1975) 2.22
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. J Virol (1999) 2.20
Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A (2000) 2.16
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell (1983) 2.11
Cellular alterations dependent upon the polyoma virus Hr-t function: separation of mitogenic from transforming capacities. Cell (1978) 2.05
The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene (1989) 1.94
The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology (1989) 1.93
PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res (2000) 1.90
Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J Virol (1998) 1.90
Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases. Nature (1991) 1.88
Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem (2001) 1.87
The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO J (1992) 1.85
A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol (1986) 1.84
Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med (1999) 1.82
Immunoperoxidase localization of keratin in human neoplasms: a preliminary survey. Am J Pathol (1980) 1.76
Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin. Proc Natl Acad Sci U S A (1982) 1.76
The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein. EMBO J (1990) 1.72
Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol (2001) 1.68
Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci U S A (2001) 1.67
The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol (1993) 1.67
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A (1994) 1.66
Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am J Physiol (1993) 1.66
Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology (1994) 1.64
Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol (1988) 1.64
Isolation and molecular characterization of a highly polymorphic centromeric tandem repeat in the family Falconidae. Genomics (1988) 1.63
Variation in caregiver perceptions of teamwork climate in labor and delivery units. J Perinatol (2006) 1.62
Apoptosis and the cell cycle. J Cell Biochem (1995) 1.60
Crystal structure of chemically synthesized [N33A] stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 "fusin" coreceptor. Proc Natl Acad Sci U S A (1998) 1.58
Role of conformational epitopes expressed by human papillomavirus major capsid proteins in the serologic detection of infection and prophylactic vaccination. Gynecol Oncol (1994) 1.58
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene (1997) 1.58
Immunization with a pentameric L1 fusion protein protects against papillomavirus infection. J Virol (2001) 1.55
Modulation of amblyopia therapy following early surgery for unilateral congenital cataracts. Br J Ophthalmol (1995) 1.48
An epidemiological study of Pasteurella haemolytica in calves. Br Vet J (1973) 1.48
Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J Clin Invest (1999) 1.46
In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J Exp Med (1998) 1.46
The significance of scapular fractures. J Trauma (1985) 1.45
pH-dependent fusion induced by vesicular stomatitis virus glycoprotein reconstituted into phospholipid vesicles. J Biol Chem (1984) 1.44
Bacteriocin production by transformable group H streptococci. J Bacteriol (1972) 1.43
Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun (1999) 1.41
Properties of a Streptococcus sanguis (group H) bacteriocin and its separation from the competence factor of transformation. J Bacteriol (1973) 1.41
Delayed traumatic intracerebral hematomas: "Spät-Apoplexie". Report of two cases. J Neurosurg (1990) 1.40
Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem (1996) 1.40
The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem (1997) 1.38
Epidemiological studies on Pasteurella Haemolytica in sheep. J Comp Pathol (1966) 1.36
Receptor-mediated endocytosis in cultured fibroblasts: cryptic coated pits and the formation of receptosomes. J Histochem Cytochem (1981) 1.35
Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells. J Virol (1982) 1.34
Changes in hospital antibiotic therapy after a quality-of-use study. Lancet (1977) 1.33
DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein. Virology (1988) 1.33
Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest (1996) 1.33
Subcellular localization and rolling circle replication of peach latent mosaic viroid: hallmarks of group A viroids. J Virol (1999) 1.24
Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery (1986) 1.24
Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol (1996) 1.21
HPV-1 L1 protein expressed in cos cells displays conformational epitopes found on intact virions. Virology (1992) 1.21
Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol (1996) 1.20
Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Exp Mol Pathol (2000) 1.20
Expression of a bovine rhodopsin gene in Xenopus oocytes: demonstration of light-dependent ionic currents. Proc Natl Acad Sci U S A (1988) 1.20
Keratin protein domains within the human epidermis. Exp Cell Res (1981) 1.19
The functional and physical form of mammalian cytochrome c oxidase determined by gel filtration, radiation inactivation, and sedimentation equilibrium analysis. J Biol Chem (1984) 1.18
Selective isolation of newly synthesized mammalian mRNA after in vivo labeling with 4-thiouridine or 6-thioguanosine. Anal Biochem (1988) 1.18
Representative cDNA libraries and their utility in gene expression profiling. Biotechniques (1999) 1.17
Coagulation changes in individuals with sickle cell trait. Am J Hematol (2002) 1.16
Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest (1995) 1.16
The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA. Virology (1996) 1.15
Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J Virol (1994) 1.15
Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene (1998) 1.15
Molecular characterization of the human gene encoding an abundant 61 kDa protein specific to the retinal pigment epithelium. Hum Mol Genet (1995) 1.15
Abdominal surgery in patients undergoing long-term peritoneal dialysis. Surgery (1982) 1.15
A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology (1994) 1.15
RFLP mapping of genes affecting plant height and growth habit in rye. Theor Appl Genet (1993) 1.15
The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene (1998) 1.14